{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:55:16Z","timestamp":1793040916107,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Mature dendritic cells release exosomes; however, the immunological role of exosomes in dendritic cell vaccine therapy remains unclear. We examined the immunogenicity of neoantigen peptide-pulsed dendritic cell-derived exosomes (Neo-P DEX) and investigated their role in vaccine therapy. The quality of DEX derived from dendritic cell cultures was confirmed via electron microscopy, western blotting, flow cytometry, and CD63 ELISA. When DEX released from neoantigen-pulsed DCs was applied to monocytes, they showed dendritic cell-like properties such as surface antigen expression. Furthermore, monocytes receiving Neo-P DEX activated neoantigen-reactive T lymphocytes. Fluorescence-activated cell sorting (FACS) analysis showed that plasma exosomes after neoantigen-pulsed DC vaccine may contain more DEX compared to before the vaccine, suggesting that DEX released after DC vaccination may be involved in the amplification of tumor-specific immune responses by translocating to monocytes in the patient body and transforming them into antigen-presenting dendritic cells. This study suggests that dendritic cell exosomes may act as endogenous neoantigen vaccines or immune amplifiers.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1565696","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T04:10:52Z","timestamp":1747627852000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Shinji","family":"Morisaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Umebayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poh Yin","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Kiyotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Torisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0899","article-title":"Cancer immunotherapy comes of age","volume":"29","author":"Topalian","year":"2011","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101721-061120","article-title":"T cell responses to SARS-CoV-2","volume":"41","author":"Sette","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.12.007","article-title":"Re-emergence of dendritic cell vaccines for cancer treatment","volume":"4","author":"Saxena","year":"2018","journal-title":"Trends Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1328341","article-title":"Trial watch: dendritic cell-based anticancer immunotherapy","volume":"6","author":"Garg","year":"2017","journal-title":"Oncoimmunology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.154","article-title":"Targeting neoantigens to augment antitumour immunity","volume":"17","author":"Yarchoan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa3828","article-title":"Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2020.1778721","article-title":"Intranodal administration of neoantigen peptide-loaded dendritic cell vaccine elicits epitope-specific T cell responses and clinical effects in a patient with chemorefractory ovarian cancer with Malignant ascites","volume":"50","author":"Morisaki","year":"2021","journal-title":"Immunol Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15213","article-title":"Efficacy of intranodal neoantigen peptide-pulsed dendritic cell vaccine monotherapy in patients with advanced solid tumors: A retrospective analysis","volume":"41","author":"Morisaki","year":"2021","journal-title":"Anticancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"13590","DOI":"10.1038\/s41598-021-91358-1","article-title":"Neoantigens elicit T cell responses in breast cancer","volume":"11","author":"Morisaki","year":"2021","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2021.1973491","article-title":"Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma","volume":"51","author":"Ichimiya","year":"2022","journal-title":"Immunol Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102438","article-title":"Lymph nodes as anti-tumor immunotherapeutic tools: intranodal-tumor-specific antigen-pulsed dendritic cell vaccine immunotherapy","volume":"14","author":"Morisaki","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1223331","article-title":"Immunological analysis of hybrid neoantigen peptide encompassing class I\/II neoepitope-pulsed dendritic cell vaccine","volume":"14","author":"Morisaki","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.5.3081","article-title":"Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition","volume":"180","author":"Montecalvo","year":"2008","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature09863","article-title":"Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection","volume":"471","author":"Wakim","year":"2011","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxf048","article-title":"Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells","volume":"14","author":"Vincent-Schneider","year":"2002","journal-title":"Int Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.4.2126","article-title":"Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC Class I\/peptide complexes to dendritic cells","volume":"172","author":"Andr\u00e9","year":"2004","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1038\/s41598-017-16609-6","article-title":"Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo","volume":"7","author":"Wahlund","year":"2017","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0679-8","article-title":"Extracellular vesicle-mediated MHC cross-dressing in immune homeostasis, transplantation, infectious diseases, and cancer","volume":"40","author":"Zeng","year":"2018","journal-title":"Semin Immunopathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI87316","article-title":"Extracellular vesicles: masters of intercellular communication and potential clinical interventions","volume":"126","author":"Pitt","year":"2016","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153667","article-title":"DC-derived exosomes for cancer immunotherapy","volume":"13","author":"Yao","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13046-020-01781-x","article-title":"Dexosomes as a cell-free vaccine for cancer immunotherapy","volume":"39","author":"Nikfarjam","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13498","article-title":"Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens","volume":"109","author":"Kiyotani","year":"2018","journal-title":"Cancer Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-021-00950-w","article-title":"Immunogenomics in personalized cancer treatments","volume":"66","author":"Kiyotani","year":"2021","journal-title":"J Hum Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J\u00a0Extracell Vesicles"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2015.11.002","article-title":"Cross-dressing: an alternative mechanism for antigen presentation","volume":"168","author":"Campana","year":"2015","journal-title":"Immunol Lett"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055700","article-title":"Antigen presentation by extracellular vesicles from professional antigen-presenting cells","volume":"36","author":"Lindenbergh","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01643","article-title":"Current concepts of antigen cross-presentation","volume":"9","author":"Embgenbroich","year":"2018","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.10.021","article-title":"Complete remission of tumors in mice with neoantigen-painted exosomes and anti-PD-1 therapy","volume":"31","author":"Zhang","year":"2023","journal-title":"Mol Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02448-z","article-title":"Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models","volume":"69","author":"Zhang","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01276","article-title":"Antigen cross-presentation by macrophages","volume":"11","author":"Muntjewerff","year":"2020","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1038\/s41467-018-04985-0","article-title":"Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway","volume":"9","author":"Tang-Huau","year":"2018","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344417","article-title":"Triggering of NF-\u03baB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy","volume":"44","author":"Pfeiffer","year":"2014","journal-title":"Eur J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2174\/1573395054065115","article-title":"Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression","volume":"1","author":"Liu","year":"2005","journal-title":"Curr Immunol Rev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008","article-title":"Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes","volume":"84","author":"Trinchieri","year":"1994","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2200069","article-title":"Inflammatory chemokine receptors support inflammatory macrophage and dendritic cell maturation","volume":"6","author":"Bartolini","year":"2022","journal-title":"Immunohorizons"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-018-0005-3","article-title":"Chemokine and chemotactic signals in dendritic cell migration","volume":"15","author":"Tiberio","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12554","article-title":"Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration","volume":"12","author":"Arraud","year":"2014","journal-title":"J Thromb Haemost"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.04.017","article-title":"Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming","volume":"25","author":"Allan","year":"2006","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-338004","article-title":"Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes","volume":"119","author":"Montecalvo","year":"2012","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"21447","DOI":"10.1038\/s41598-023-48376-y","article-title":"Porcine milk exosomes modulate the immune functions of CD14+ monocytes in vitro","volume":"13","author":"\u00c1vila Morales","year":"2023","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.060453","article-title":"Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens","volume":"169","author":"Obregon","year":"2006","journal-title":"Am J Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939407","article-title":"B7-1\/2, but not PD-L1\/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function","volume":"39","author":"Ruffner","year":"2009","journal-title":"Eur J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1008347","article-title":"Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival","volume":"4","author":"Muller","year":"2015","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1565696\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T04:10:54Z","timestamp":1747627854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1565696\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2025.1565696"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1565696","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"article-number":"1565696"}}